Twilight Litaka Pharma Ltd.
NSE: TWILITAKA | BSE: 506985
₹2.88
₹-0.15
(-4.95%)
As on 01-Jan-2015IST
Market cap
₹7 Cr
Revenue (TTM)
₹13 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-140 Cr
-
ROE
0 %
-
ROCE
-55 %
-
Industry P/E
45.88
-
EV/EBITDA
164.1
-
Debt to Equity
-0.2
-
Book Value
₹--
-
EPS
₹-59.4
-
Face value
5
-
Shares outstanding
24,781,285
10 Years Aggregate
CFO
₹-13.09 Cr
EBITDA
₹309.53 Cr
Net Profit
₹-163.59 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Twilight Litaka Pharma
| -5.0 | -23.8 | -38.5 | -24.8 | -48.8 | -49.2 | -18.6 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
BSE Healthcare#
| 10.2 | 1.2 | 12.0 | 10.9 | 24.0 | 14.1 | 12.4 |
|
Company
|
2014
|
|---|---|
|
Twilight Litaka Pharma
| -24.4 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Twilight Litaka Pharma
|
2.9 | 7.1 | 12.6 | -147.2 | -23.9 | -- | -- | 0.0 |
| 3,246.2 | 26,558.6 | 1,339.4 | 356.4 | 33.2 | 23.2 | 74.5 | 16.1 | |
| 405.9 | 15,522.7 | 2,268.6 | 150.1 | 10.6 | 5.4 | 86.6 | 4.0 | |
| 786.9 | 19,473.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.7 | 3.8 | |
| 889.0 | 15,918.4 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.2 | 1.7 | |
| 1,608.6 | 18,428.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 158.9 | 21,141.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.6 | |
| 1,361.8 | 22,492.1 | 1,284.3 | 134.4 | -- | 30.7 | 91.2 | 17.5 | |
| 440.8 | 17,797.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 56.2 | 3.7 | |
| 2,011.1 | 32,676.4 | 3,373.0 | 199.0 | 12.6 | 5.9 | 153.4 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Twilight Litaka Pharma
--
-
Incorporated
1974
-
Chairman
R C Bora
-
Managing Director
Gopal Ramourti
-
Headquarters
Pune, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsFinancial Results for Dec 31, 2014 (Standalone)
24-Feb-2015Financial Results for Sept 30, 2014 (Standalone)
19-Nov-2014Financial Results for June 30, 2014 (Audited)
10-Sep-2014Financial Results for Mar 31, 2014
21-May-2014Shareholding Pattern For March 31, 2014
22-Apr-2014Financial Results for Dec 31, 2013
18-Feb-2014No News & Announcements are available.
FAQs for Twilight Litaka Pharma
What is the current share price of Twilight Litaka Pharma Ltd Today?
The share price of Twilight Litaka Pharma Ltd is ₹2.88 (BSE) and ₹4.25 (NSE) as of 01-Jan-2015 IST. Twilight Litaka Pharma Ltd has given a return of -48.75% in the last 3 years.
What is the current PB & PE ratio of Twilight Litaka Pharma Ltd?
Since, TTM earnings of Twilight Litaka Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Twilight Litaka Pharma Ltd is -0.05 times as on 01-Jan-2015, a 101 discount to its peers’ median range of 3.97 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2014
|
0.00
|
-0.11
|
|
2012
|
0.00
|
0.53
|
|
2011
|
2.33
|
0.85
|
|
2010
|
6.04
|
2.12
|
|
2009
|
2.58
|
0.89
|
What is the 52 Week High and Low of Twilight Litaka Pharma Ltd?
The 52-week high and low of Twilight Litaka Pharma Ltd are Rs -- and Rs -- as of 22-Jun-2026.
What is the market cap of Twilight Litaka Pharma Ltd?
Twilight Litaka Pharma Ltd has a market capitalisation of ₹ 7 Cr as on 01-Jan-2015. As per SEBI classification, it is a company.
Should I invest in Twilight Litaka Pharma Ltd?
Before investing in Twilight Litaka Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.